Augusto Villegas

8.7k total citations · 1 hit paper
27 papers, 851 citations indexed

About

Augusto Villegas is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Augusto Villegas has authored 27 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 7 papers in Surgery. Recurrent topics in Augusto Villegas's work include Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Augusto Villegas is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Augusto Villegas collaborates with scholars based in Spain, United States and Japan. Augusto Villegas's co-authors include Shuji Murakami, Mustafa Özgüroğlu, Davey B. Daniel, Rina Hui, Scott Antonia, Phillip A. Dennis, Jhanelle E. Gray, Corinne Faivre‐Finn, Ki Hyeong Lee and Byoung Chul Cho and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Augusto Villegas

26 papers receiving 840 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC

2019 305 citations Jhanelle E. Gray, Augusto Villegas et al. Journal of Thoracic Oncology profile →

Peers

Augusto Villegas

ONCOL

PRM

RNMI

IMMUN

SURGE

Anna-Larissa N. Niemeijer Netherlands

Marco Angelo Burgio Italy

Hayato Kawachi Japan

Antonello Veccia Italy

Charles Ricordel France

Gilles Quéré France

Sonia Yip Australia

Jinbo Yue China

Anna Bettini Italy

Anna-Larissa N. Niemeijer Netherlands

Augusto Villegas

805 ×1.3

ONCOL

457 ×0.8

PRM

238 ×1.6

RNMI

262 ×2.9

IMMUN

77 ×1.0

SURGE

Citations per year, relative to Augusto Villegas Augusto Villegas (= 1×) peers Anna-Larissa N. Niemeijer

Countries citing papers authored by Augusto Villegas

Since Specialization

Citations

This map shows the geographic impact of Augusto Villegas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Augusto Villegas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Augusto Villegas more than expected).

Fields of papers citing papers by Augusto Villegas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Augusto Villegas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Augusto Villegas. The network helps show where Augusto Villegas may publish in the future.

Co-authorship network of co-authors of Augusto Villegas

This figure shows the co-authorship network connecting the top 25 collaborators of Augusto Villegas. A scholar is included among the top collaborators of Augusto Villegas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Augusto Villegas. Augusto Villegas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vansteenkiste, Johan, Jarushka Naidoo, Corinne Faivre‐Finn, et al.. (2024). Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC. JTO Clinical and Research Reports. 5(3). 100638–100638. 6 indexed citations

Patel, Jay & Augusto Villegas. (2023). Urachal Adenocarcinoma: A Rare Primary Cancer Managed With FOLFOX Chemotherapy. Cureus. 15(8). e43849–e43849. 1 indexed citations

Villegas, Augusto, et al.. (2022). COVID-19: A Rare Cause of Hemolytic Uremic Syndrome. Cureus. 14(8). e27962–e27962. 5 indexed citations

Senan, Suresh, Mustafa Özgüroğlu, Davey B. Daniel, et al.. (2022). Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial. ESMO Open. 7(2). 100410–100410. 14 indexed citations

Socinski, Mark A., Mustafa Özgüroğlu, Augusto Villegas, et al.. (2021). Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC). Clinical Lung Cancer. 22(6). 549–561. 30 indexed citations

Faivre‐Finn, Corinne, David R. Spigel, Suresh Senan, et al.. (2020). Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC). Lung Cancer. 151. 30–38. 31 indexed citations

Gray, Jhanelle E., Augusto Villegas, Davey B. Daniel, et al.. (2019). Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC. Journal of Thoracic Oncology. 15(2). 288–293. 305 indexed citations breakdown →

Gray, Jhanelle E., Augusto Villegas, Davey B. Daniel, et al.. (2019). Three-year overall survival update from the PACIFIC trial.. Journal of Clinical Oncology. 37(15_suppl). 8526–8526. 25 indexed citations

Spigel, David R., Johan Vansteenkiste, Martin Reck, et al.. (2018). P1.16-05 Effect of Induction Chemotherapy in the PACIFIC Study. Journal of Thoracic Oncology. 13(10). S629–S629. 1 indexed citations

10.

Vansteenkiste, Johan, Jarushka Naidoo, Corinne Faivre‐Finn, et al.. (2018). MA05.02 PACIFIC Subgroup Analysis: Pneumonitis in Stage III, Unresectable NSCLC Patients Treated with Durvalumab vs. Placebo After CRT. Journal of Thoracic Oncology. 13(10). S370–S371. 30 indexed citations

11.

Peters, Solange, Rolf A. Stahel, Lukas Bubendorf, et al.. (2018). Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers. Clinical Cancer Research. 25(1). 64–72. 173 indexed citations

12.

Raben, David, Corinne Faivre‐Finn, David R. Spigel, et al.. (2018). PACIFIC: Overall Survival with Durvalumab versus Placebo after Chemoradiotherapy in Stage III NSCLC. International Journal of Radiation Oncology*Biology*Physics. 102(5). 1607–1608. 2 indexed citations

13.

Villegas, Augusto, et al.. (2017). Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibitor Therapy. Case Reports in Oncological Medicine. 2017(1). 5063405–5063405. 11 indexed citations

14.

Murakami, Shuji, Mustafa Özgüroğlu, Augusto Villegas, et al.. (2017). PACIFIC: A double-blind, placebo-controlled Phase III study of durvalumab as consolidation therapy after chemoradiation in patients with locally advanced, unresectable NSCLC. Annals of Oncology. 28. x122–x122. 2 indexed citations

15.

Paz‐Ares, Luis, Augusto Villegas, Davey B. Daniel, et al.. (2017). PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy (CRT) in patients with stage III, locally advanced, unresectable NSCLC. Annals of Oncology. 28. v634–v634. 1 indexed citations

16.

Villegas, Augusto, et al.. (2009). Aortic dissection after open repair of an infrarenal aortic aneurysm. International Journal of Angiology. 18(3). 143–146. 2 indexed citations

17.

Anguita, Eduardo, et al.. (1998). [Usefulness of molecular screening in childhood lymphoblastic leukemias].. PubMed. 43(1). 7–11. 2 indexed citations

18.

González, Fernando A., Augusto Villegas, Maria Teresa Ferrò, et al.. (1993). Usefulness of the rearrangement of the bcr/abl gene in extramedullary (lymph nodes) blast crisis diagnosed in chronic myeloid leukaemia. British Journal of Haematology. 84(2). 351–352. 8 indexed citations

19.

Villegas, Augusto, et al.. (1993). [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].. PubMed. 101(14). 521–4.

20.

Villegas, Augusto, et al.. (1992). [Second neoplasms as a late complication of the treatment of Hodgkin's disease].. PubMed. 37(6). 429–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact